CD19 CAR-T expressing IL7 and CCL19

· Second Affiliated Hospital, School of Medicine, Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19 CAR-T expressing IL7 and CCL19, covering 2025-07-16 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma